DCM-DETECT: Dilated Cardiomyopathy Detection using AI and screening with mobile Technology
Enrolling By Invitation
18-100 years
All
Phase
N/A
170 participants needed
Brief description of study
At home care (AHC) Artificial Intelligence
Electrocardiogram (AI-ECG) can improve cardiac screening by echocardiogram for
first degree relatives (FDR) of patients with dilated cardiomyopathy (DCM).
Probands will contact their FDRs about testing with an AI-ECG mobile device.
This study compares the impact of screening FDR of probands with DCM using a
mobile ECG with the ability to transmit the ECG for cloud based AI analysis to
detect heart function.
Detailed description of study
This study has two components: probands and FDRs. The purpose
of the study is to determine how many biological FDRs (parents, siblings, or
children) of people with DCM undergo heart screening via TTE.
Eligible probands will have:
• A
diagnosis of DCM and
• At least
one FDR who does not know that you have DCM
The second part of the study aims to measure how many FDRs
choose to get a screening echo done after taking part in the study. FDRs who
agree to participate will use a handheld electrocardiogram (ECG) device that
records an ECG in 30-second to 5-minute time periods. The smart device, the 6-lead
AliveCor Kardia (Kardia), is approved by the US Food and Drug Administration
(FDA). It uses an Artificial Intelligence (AI) algorithm to predict how likely
it is that users have reduced heart function.
Eligible FDRs have:
• A
relative with a diagnosis of DCM
• Not been
screened before for DCM
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Dilated Cardiomyopathy, LVEF
-
Age: Between 18 Years - 100 Years
-
Gender: All
Inclusion Criteria:
Probands
- Confirmed diagnosis of DCM
- Have at least one living adult first degree relative
FDRs
- Have a first degree relative who has a confirmed diagnosis of DCM
- Access to a smartphone or smart device with cellular data or Wi-Fi access
Exclusion Criteria:
Probands
- Have already talked to FDR about undergoing cardiac screening
- Congenital structural heart disease
- Severe and untreated or untreatable hypertension
- Known secondary cause of DCM such as pregnancy, myocarditis, alcohol abuse, etc.
FDRs
- Previously informed about cardiac screening or has completed cardiac screening by TTE
- Previously diagnosed with reduced LVEF
Updated on
06 Aug 2024.
Study ID: 855484
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
